Patients The rise of prescription drug abuse and drug diversion As prescription drug abuse has grown in the US and Europe, the diversion of such treatments from legitimate sources has also increased.
Views & Analysis Lilly’s Mounjaro wins latest head-to-head battle in clinical... Diabetes is one of the most common health conditions in the United States, afflicting more than 11% of the population, with over 90% included in the type 2 category.
News Azithromycin for mild-to-moderate COVID-19 Azithromycin has been widely evaluated for its efficacy against COVID-19.
Partner Content Partner Content Customer experience: shaping digital healthcare How pharma is using modern tech to improve treatment
Partner Content Partner Content Understanding Multiple Sclerosis Informative downloadable pack on Multiple Sclerosis
Partner Content Partner Content Patient Organisations role in Orphan Drugs clinical developm... Orphan Drugs and Rare Diseases Conference - London
R&D Modelling biologics: Challenges and opportunities, with Dr D... From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.